News
From Undruggable to Unstoppable: A New Cancer Cure Target Emerges
Roughly a quarter of all cancerous tumors are caused by mutations in the KRAS gene, which fosters cell growth. For more than three decades, scientists believed these mutations were impervious to treatment. Today, National Institutes of Health (NIH)-funded discoveries by UC San Francisco Professor of
How to Thwart Cancer: Drug the Cells It Uses to Grow and Shapeshift
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting. Until now, it was not clear whether the cells promote cancer inside the body. Now we know they do, and how
UCSF Urology Clinicians Present Research Findings at SurgeWest 2025
Development of a novel RNA biomarker for prostate cancer detection using seminal fluid and mismatched opioid prescriptions following urologic surgery are among the topics being presented by UCSF clinicians and researchers at the Western Section of the American Urological Association’s SurgeWest 2025
‘Every Time I Relapsed, There Would Be a New Course of Therapy’
Lee May’s friends tried to assure him he’d only broken a rib on their marathon bicycle ride. But May, saddled with bone pain and fatigue, was certain it was more. He underwent testing at UCSF Health, including a bone marrow biopsy, then left on a long-planned vacation to Venice. “I knew it was going
Showcasing Art that Celebrates Creativity and Healing Amid Cancer
They aren’t professional artists, and to have their work featured by a major metropolitan museum seemed unfathomable. They’d been diagnosed with a gamut of cancers including brain cancer, breast cancer, multiple myeloma, colon, ovarian cancer. Some were diagnosed many years ago, others as recently
UCSF Radiation Oncologists Featured at Radiation Oncology Conference
UC San Francisco researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco, which ran from Sept. 27 to Oct. 1. The 67th ASTRO annual meeting was centered around the theme of “Rediscovering
UCSF Surgeons, Researchers Share Expertise at Surgical Conference
Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians, and researchers discussed at the American College of Surgeon’s 2025 Clinical Congress in Chicago